Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patrick Schnell
Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial
Oncologist
Cancer Research
Medicine
Oncology
Factors Associated With Sinus Bradycardia During Crizotinib Treatment: A Retrospective Analysis of Two Large-Scale Multinational Trials (PROFILE 1005 and 1007)
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Ribociclib With Letrozole vs Letrozole Alone in Elderly Patients With Hormone Receptor-Positive, HER2-negative Breast Cancer in the Randomized MONALEESA-2 Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
TBCRC 002: A Phase II, Randomized, Open-Label Trial of Preoperative Letrozole With or Without Bevacizumab in Postmenopausal Women With Newly Diagnosed Stage 2/3 Hormone Receptor-Positive and HER2-negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cost-Effectiveness of Palbociclib Plus Letrozole Versus Letrozole Alone as a First-Line Treatment in Women With Oestrogen Receptor-Positive, HER2-negative, Advanced Breast Cancer. Revised Results for the Swiss Health Care Setting
Breast Cancer Research and Treatment
Cancer Research
Oncology
Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn180 - Pharmacoeconomic Assessment of Fulvestrant Versus Dd (Doxorubicin, Docetaxel) Therapy in Postmenopausal Women With Metastatic Er (+) Her2 (-) Breast Cancer in Ukraine
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist
Cancer Research
Medicine
Oncology
